Publications by authors named "Anestakis Doxakis"

Claim this Profile
P
Phenotypic analysis of mice with inactivation of the deubiquitinating enzyme CYLD in adipose tissue.
Christos Gonidas, Theofilos Poutahidis, Athanasios Siasiaridis, Doxakis Anestakis, Polyanthi Konstantinidou

Cell Tissue Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Sickness-Like Reaction: A Narrative Review of Epidemiology, Immunopathogenesis, Diagnostic Challenges, and Therapeutic Approaches.
Christodoulos Chatzigrigoriadis, Emmanouil Koufopoulos, Prodromos Avramidis, Ioannis Erginousakis, Vasiliki Karakoida, Doxakis Anestakis

Clin Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Unusual Cause of Neonatal Infection: A Case Report of Meningitis and Sepsis.
Dimitrios Kapnisis, Christodoulos Chatzigrigoriadis, Emmanouil Koufopoulos, Fevronia Kolonitsiou, Gabriel Dimitriou, Doxakis Anestakis

J Med Cases· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietin Reduces Inflammation, Oxidative Stress, and Apoptosis in a Rat Model of Bleomycin-Induced Idiopathic Pulmonary Fibrosis.
Drosos Tsavlis, Kalliopi Domvri, Konstantinos Porpodis, Stamatia Papoutsopoulou, Doxakis Anestakis

J Pers Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy.
Theodora Katopodi, Savvas Petanidis, Eirini Grigoriadou, Doxakis Anestakis, Charalampos Charalampidis

Pharmaceutics· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization.
Theodora Katopodi, Savvas Petanidis, Doxakis Anestakis, Charalampos Charalampidis, Ioanna Chatziprodromidou

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery.
Theodora Katopodi, Savvas Petanidis, Doxakis Anestakis, Charalampos Charalampidis, Ioanna Chatziprodromidou

Pharmaceutics· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital embryonal tumor of the central nervous system with a rapidly fatal outcome in the neonatal intensive care unit.
Ioannis Nikolaidis, Maria-Valeria Karakasi, Marina-Kleopatra Boziki, Doxakis Anestakis, Savvas Deftereos

Pediatr Blood Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of γδ-TcR or IL17a Reduces T-Cell and Neutrophil Infiltration after Ischemia/Reperfusion Injury in Mouse Liver.
Saant Al Mogrampi, Christina Boumpoureka, Hara Afaloniati, Maria Lagou, Katerina Angelopoulou, Doxakis Anestakis

J Clin Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital Supratentorial Neuroectodermal Primary Tumor: A Rare Embryonal Tumor With an Uncommon Clinical Presentation.
Eirini Giovannopoulou, Maria-Valeria Karakasi, Ioannis Nikolaidis, Doxakis Anestakis, Savvas Deftereos

Am J Forensic Med Pathol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy.
Theodora Katopodi, Savvas Petanidis, Drosos Tsavlis, Doxakis Anestakis, Charalampos Charalampidis

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8T Cell Immunity.
Kalliopi Domvri, Savvas Petanidis, Paul Zarogoulidis, Doxakis Anestakis, Charalampos Charalampidis

Int J Nanomedicine· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiphospholipid Syndrome and Preeclampsia in Pregnancy: A Case Report.
Rafailia Skoura, Paraskevi-Eva Andronikidi, Doxakis Anestakis, Savvas Petanidis, Eirini Orovou

Cureus· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and Immune Phenotypic Modifications during Metastatic Dissemination in Lung Carcinogenesis.
Drosos Tsavlis, Theodora Katopodi, Doxakis Anestakis, Savvas Petanidis, Charalampos Charalampidis

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered Distribution and Expression of Syndecan-1 and -4 as an Additional Hallmark in Psoriasis.
Eleni Koliakou, Manthou Maria Eleni, Ioanna Koumentakou, Nikolaos Bikiaris, Polyanthi Konstantinidou, Doxakis Anestakis

Int J Mol Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of coupling heparin to crosslinked collagen I/III scaffolds for human dermal fibroblast subpopulations' tissue growth.
Anna Michopoulou, Eleni Koliakou, Zoi Terzopoulou, Patricia Rousselle, Artemis Palamidi, Doxakis Anestakis

J Biomed Mater Res A· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kras-driven intratumoral heterogeneity triggers infiltration of M2 polarized macrophages via the circHIPK3/PTK2 immunosuppressive circuit.
Theodora Katopodi, Savvas Petanidis, Kalliopi Domvri, Paul Zarogoulidis, Doxakis Anestakis

Sci Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treg-dependent immunosuppression triggers effector T cell dysfunction via the STING/ILC2 axis.
Kalliopi Domvri, Savvas Petanidis, Paul Zarogoulidis, Doxakis Anestakis, Drosos Tsavlis

Clin Immunol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosomal lncRNA PCAT-1 promotes Kras-associated chemoresistance via immunosuppressive miR-182/miR-217 signaling and p27/CDK6 regulation.
Kalliopi Domvri, Savvas Petanidis, Doxakis Anestakis, Konstantinos Porpodis, Chong Bai

Oncotarget· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual photothermal MDSCs-targeted immunotherapy inhibits lung immunosuppressive metastasis by enhancing T-cell recruitment.
Kalliopi Domvri, Savvas Petanidis, Doxakis Anestakis, Konstantinos Porpodis, Chong Bai

Nanoscale· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin chemoresistance is associated with CD11b/Ly6C myeloid release and upregulation of TIGIT and LAG3/CD160 exhausted T cells.
Doxakis Anestakis, Savvas Petanidis, Kalliopi Domvri, Drosos Tsavlis, Paul Zarogoulidis

Mol Immunol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of kras-derived exosomes downregulates immunosuppressive BACH2/GATA-3 expression via RIP-3 dependent necroptosis and miR-146/miR-210 modulation.
Savvas Petanidis, Kalliopi Domvri, Konstantinos Porpodis, Doxakis Anestakis, Lutz Freitag

Biomed Pharmacother· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autophagy inhibition upregulates CD4 tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activation.
Paul Zarogoulidis, Savvas Petanidis, Kalliopi Domvri, Efrosini Kioseoglou, Doxakis Anestakis

Mol Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis